Qvanteq AG has developed a surface modification – not a coating – that renders titanium alloy-based implants antithrombogenic. Extensive studies have shown that the modified surface suppresses the activation of proteins of the blood coagulation cascade. The technology can be extended from titanium alloys to virtually any material used in medical devices and is therefore […]
Qvanteq, togehter with partners, has developed a process that can render any material, or medical devices made up from a combination of materials, antithrombotic. For inquiries please contact the company.
Qvanteq AG has developed a fast and simple method to screen materials used for medical devices with respect to their thrombus formation capacity. Respective work is normally done using whole human blood. For inquiries please contact the company.
Qvanteq AG has moved into new offices at the Technopark in Zürich.
Differential protein adsorption of surface treated Nitinol alloys regulates blood activation K Gegenschatz-Schmid, S Buzzi, J Grossmann, B Roschitzki, D Glück, A Zucker, M Ehrbar Recent research results were presented at the 2019 Annual Meeting of the Swiss Society for Biomaterials + Regenerative Medicine. Abstract: Stents were developed for overcoming heart attacks and strokes caused […]